STOK

Stoke Therapeutics, Inc.

4.05 USD

Last updated Nov 28, 12:22 UTC

Yesterday HIGH

$4.09

Yesterday LOW

$3.95

52w HIGH

$14

52w LOW

$3.35

EPS

-0.55

PE

-7.36

Next Earnings

Mar 4, 2024

Overview News Government Trades

Stoke Therapeutics, Inc. stock is up 13.45% since 30 days ago. The next earnings date is Mar 4, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 November’s closed higher than October. 100% of analysts rate it a buy.

Stoke Therapeutics, Inc. develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

stoketherapeutics.com

Benzinga Insights

Thu Jul 27, 2023

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 56 stocks hit new 52-week lows.
Benzinga Insights

Wed Jul 26, 2023

Stocks That Hit 52-Week Lows On Wednesday

Wednesday saw 59 companies set new 52-week lows.
Lisa Levin

Tue Jul 25, 2023

Crude Oil Up 1%; Verizon Earnings Beat Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&P 500, also rose, gaining, 0.48% to 4,576.60.
Benzinga Insights

Tue Jul 25, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Lisa Levin

Tue Jul 25, 2023

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Vandana Singh

Tue Jul 25, 2023

Why Stoke Therapeutics Is Trading Lower Today?

Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) study in children and
Benzinga Insights

Tue Jul 25, 2023

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 56 companies set new 52-week lows.
Benzinga Insights

Tue Jul 25, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Newsdesk

Tue Jul 25, 2023

Stoke Therapeutics Announced New Safety And Efficacy Data From STK-001 In Two Ongoing Phase 1/2A Studies And The Open-label Extension Study In Children And Adolescents With Dravet Syndrome, Suggesting Clinical Benefit
Lisa Levin

Mon Jul 24, 2023

Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.